Ana Martinez (Ana Martínez)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 71

Top Venues

Journal of medicinal chemistry

Journal of enzyme inhibition and medicinal chemistry

International journal of molecular sciences

Expert opinion on investigational drugs

Consejo Superior de Investigaciones Científicas

Universidad Complutense de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Consejo Superior de Investigaciones Científicas Mar 01 1990

Spain

Profesor de Investigacion :: Centro de Investigaciones Biologicas

Education History

Universidad Complutense de Madrid Mar 25 1987

Spain

PHD :: Facultad de CC Quimicas

Publications

Elisa Rojas-Prats, Loreto Martínez-González, Carmen Gil, David Ramírez, Ana Martinez
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Elisa Rojas-Prats, Loreto Martínez-González, Carmen Gil, David Ramírez, Ana Martinez
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Rocío Benítez-Fernández, Fernando Josa-Prado, Estefanía Sánchez, Yolanda Lao, Alfonso García-Rubia, José Cumella, Ana Martinez, Valle Palomo, Fernando de Castro
Efficacy of a benzothiazole-based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis. CNS neuroscience & therapeutics 30 (1) (2024)
Marcos Morales-Tenorio, Fátima Lasala, Alfonso Garcia-Rubia, Elnaz Aledavood, Michelle Heung, Catherine Olal, Beatriz Escudero-Pérez, Covadonga Alonso, Ana Martinez, César Muñoz-Fontela, Rafael Delgado, Carmen Gil
Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood-Brain Barrier-Permeable Ebola Virus Entry Inhibitors. Journal of medicinal chemistry (2024)
Elisa Rojas-Prats, Loreto Martínez-González, Carmen Gil, David Ramírez, Ana Martinez
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Elisa Rojas-Prats, Loreto Martínez-González, Carmen Gil, David Ramírez, Ana Martinez
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Rocío Benítez-Fernández, Fernando Josa-Prado, Estefanía Sánchez, Yolanda Lao, Alfonso García-Rubia, José Cumella, Ana Martinez, Valle Palomo, Fernando de Castro
Efficacy of a benzothiazole-based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis. CNS neuroscience & therapeutics 30 (1) (2024)
Ines Maestro, Enrique Madruga, Patricia Boya, Ana Martinez
Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Yang Zheng, Susanne Schroeder, Georgi K Kanev, Sanaa S Botros, Samia William Abdel-Sayed, Abdel-Nasser A Sabra, Louis Maes, Guy Caljon, Carmen Gil, Ana Martinez, Irene G Salado, Koen Augustyns, Ewald Edink, Maarten Sijm, Erik de Heuvel, Iwan J P de Esch, Tiffany van der Meer, Marco Siderius, Geert Jan Sterk, David Brown, Rob Leurs
To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A? International journal of molecular sciences 24 (7) (2023)
Alfonso Garcia-Rubia, Fátima Lasala, Tiziana Ginex, Marcos Morales-Tenorio, Catherine Olal, Michelle Heung, Paola Oquist, Inmaculada Galindo, Miguel Ángel Cuesta-Geijo, José M Casasnovas, Nuria Eugenia Campillo, Angeles Canales, Covadonga Alonso, Ana Martinez, César Muñoz-Fontela, Rafael Delgado, Carmen Gil
N '-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile. Journal of medicinal chemistry (2023)
Loreto Martínez-González, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs 32 (2) (2023)
Guiomar Rodríguez-Periñán, Ana de la Encarnación, Fermín Moreno-Izco, Adolfo Lopez de Munain, Ana Martinez, Ángeles Martín-Requero, Carolina Alquézar, Fernando Bartolomé
Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Loreto Martínez-González, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs 32 (2) (2023)
Loreto Martínez-González, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs 32 (2) (2023)
Ines Maestro, Enrique Madruga, Patricia Boya, Ana Martinez
Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Loreto Martínez-González, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs (2023)
Guiomar Rodríguez-Periñán, Ana de la Encarnación, Fermín Moreno-Izco, Adolfo Lopez de Munain, Ana Martinez, Ángeles Martín-Requero, Carolina Alquézar, Fernando Bartolomé
Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Alejandro Rabanal Basalo, Mercedes Navarro Pablos, Nuria Viejo Pinero, María Luz Vila Méndez, Verónica Molina Barcena, Aránzazu Montilla Bernabé, María Del Pilar Villanueva Morán, Ana María Blanco Gallego, Carmen Guirao Sánchez, Salvador Juárez Antón, Ángela Fernández Rodríguez, María Luisa Revuelta Puigdollers, María Teresa Sarriá Sánchez, Carmen Martín Alegre, Miguel Ángel Martínez Álvarez, María Mestre de Juan, Rebeca Mielgo Salvador, María Teresa Gijón Seco, José Manuel Saníger Herrera, María Esther Rodríguez Jiménez, Begoña Navas de la Peña, Javier Santa Cruz Hernández, Ana María Abad Esteban, Rebeca Díaz Martín, Laura García Pérez, Paloma Herrero Vanrell, María Isabel Arias de Saavedra Criado, Alexandra Vaquero Vinent, Verónica López Gómez, Víctor Manuel Montegrifo Rentero, Lucía Simón Miguel, Ignacio Campo Martos, Silvia Ortiz Zamorano, María Jesús Izquierdo Zamarriego, Izíar Vázquez Carrión, Rosa María López Valero, Carmen Gil, Ana Martinez, Begoña Soler-López
A randomized, double-blind study on the efficacy of oral domperidone versus placebo for reducing SARS-CoV-2 viral load in mild-to-moderate COVID-19 patients in primary health care. Annals of medicine 55 (2) (2023)
Gracia Porras, Silvana Ruiz, Inés Maestro, Daniel Borrego-Hernández, Alberto Garcia Redondo, Ana Martinez, Ángeles Martín-Requero
Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts. International journal of molecular sciences 24 (3) (2023)
Loreto Martinez-Gonzalez, Ana Martinez
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert opinion on investigational drugs (2023)
Gracia Porras, Silvana Ruiz, Inés Maestro, Daniel Borrego-Hernández, Alberto Garcia Redondo, Ana Martinez, Ángeles Martín-Requero
Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts. International journal of molecular sciences 24 (3) (2023)
Gracia Porras, Silvana Ruiz, Inés Maestro, Daniel Borrego-Hernández, Alberto Garcia Redondo, Ana Martinez, Ángeles Martín-Requero
Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts. International journal of molecular sciences 24 (3) (2023)
Ines Maestro, Enrique Madruga, Patricia Boya, Ana Martinez
Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Eva P Cuevas, Alberto Rodríguez-Fernández, Valle Palomo, Ana Martinez, Ángeles Martín-Requero
TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer's Disease Patients. Biomedicines 10 (2) (2022)
María Luz Vila Méndez, Carmen Antón Sanz, Alicia Del Rocío Cárdenas García, Amparo Bravo Malo, Francisco Javier Torres Martínez, José María Martín Moros, María Real Torrijos, José Francisco Javier Vendrell Covisa, Olga Guzmán Sierra, Verónica Molina Barcena, Nuria Viejo Pinero, Carlos Fernández Díaz, Purificación Arroyo Burguillo, Ana María Blanco Gallego, Carmen Guirao Sánchez, Aránzazu Montilla Bernabé, María Del Pilar Villanueva Morán, Salvador Juárez Antón, Ángela Fernández Rodríguez, María Ángeles Somoza Calvo, Ernesto Cerrada Cerrada, Gemma Pérez Mañas, Antonio Sánchez Calso, Frida Vallejo Somohano, Carmen Cauqui Díaz, Gloria Viñas Fernández, Jesús Molina, Marina González Godoy, Gonzalo Lumbreras García, Javier Rosado Martín, Aida Rodríguez Hernández, Sara López Antúñez, Gabriel Vázquez Perfecto, María Concepción Marcello Andrés, Nieves Marina Puente García, Carmen Gil, Ana Martinez, Begoña Soler-López
Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial. Journal of clinical medicine 12 (1) (2022)
Isabel Lastres-Becker, Eva de Lago, Ana Martinez, Javier Fernández-Ruiz
New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Biomolecules 12 (9) (2022)
María Luz Vila Méndez, Carmen Antón Sanz, Alicia Del Rocío Cárdenas García, Amparo Bravo Malo, Francisco Javier Torres Martínez, José María Martín Moros, María Real Torrijos, José Francisco Javier Vendrell Covisa, Olga Guzmán Sierra, Verónica Molina Barcena, Nuria Viejo Pinero, Carlos Fernández Díaz, Purificación Arroyo Burguillo, Ana María Blanco Gallego, Carmen Guirao Sánchez, Aránzazu Montilla Bernabé, María Del Pilar Villanueva Morán, Salvador Juárez Antón, Ángela Fernández Rodríguez, María Ángeles Somoza Calvo, Ernesto Cerrada Cerrada, Gemma Pérez Mañas, Antonio Sánchez Calso, Frida Vallejo Somohano, Carmen Cauqui Díaz, Gloria Viñas Fernández, Jesús Molina, Marina González Godoy, Gonzalo Lumbreras García, Javier Rosado Martín, Aida Rodríguez Hernández, Sara López Antúñez, Gabriel Vázquez Perfecto, María Concepción Marcello Andrés, Nieves Marina Puente García, Carmen Gil, Ana Martinez, Begoña Soler-López
Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial. Journal of clinical medicine 12 (1) (2022)
María Luz Vila Méndez, Carmen Antón Sanz, Alicia Del Rocío Cárdenas García, Amparo Bravo Malo, Francisco Javier Torres Martínez, José María Martín Moros, María Real Torrijos, José Francisco Javier Vendrell Covisa, Olga Guzmán Sierra, Verónica Molina Barcena, Nuria Viejo Pinero, Carlos Fernández Díaz, Purificación Arroyo Burguillo, Ana María Blanco Gallego, Carmen Guirao Sánchez, Aránzazu Montilla Bernabé, María Del Pilar Villanueva Morán, Salvador Juárez Antón, Ángela Fernández Rodríguez, María Ángeles Somoza Calvo, Ernesto Cerrada Cerrada, Gemma Pérez Mañas, Antonio Sánchez Calso, Frida Vallejo Somohano, Carmen Cauqui Díaz, Gloria Viñas Fernández, Jesús Molina, Marina González Godoy, Gonzalo Lumbreras García, Javier Rosado Martín, Aida Rodríguez Hernández, Sara López Antúñez, Gabriel Vázquez Perfecto, María Concepción Marcello Andrés, Nieves Marina Puente García, Carmen Gil, Ana Martinez, Begoña Soler-López
Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial. Journal of clinical medicine 12 (1) (2022)
Ines Maestro, Laura Rodriguez de la Ballina, Gracia Porras, Silvia Corrochano, Eva de Lago, Anne Simonsen, Patricia Boya, Ana Martinez
Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations. International journal of molecular sciences 23 (20) (2022)
Rocío Benítez-Fernández, Carmen Gil, Carmen Guaza, Leyre Mestre, Ana Martinez
The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis. International journal of molecular sciences 23 (22) (2022)
Vanesa Nozal, Loreto Martínez-González, Marta Gomez-Almeria, Claudia Gonzalo-Consuegra, Paula Santana, Apirat Chaikuad, Eva Pérez-Cuevas, Stefan Knapp, Daniel Lietha, David Ramírez, Sabrina Petralla, Barbara Monti, Carmen Gil, Angeles Martín-Requero, Valle Palomo, Eva de Lago, Ana Martinez
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. Journal of medicinal chemistry 65 (2) (2022)
María Luz Vila Méndez, Carmen Antón Sanz, Alicia Del Rocío Cárdenas García, Amparo Bravo Malo, Francisco Javier Torres Martínez, José María Martín Moros, María Real Torrijos, José Francisco Javier Vendrell Covisa, Olga Guzmán Sierra, Verónica Molina Barcena, Nuria Viejo Pinero, Carlos Fernández Díaz, Purificación Arroyo Burguillo, Ana María Blanco Gallego, Carmen Guirao Sánchez, Aránzazu Montilla Bernabé, María Del Pilar Villanueva Morán, Salvador Juárez Antón, Ángela Fernández Rodríguez, María Ángeles Somoza Calvo, Ernesto Cerrada Cerrada, Gemma Pérez Mañas, Antonio Sánchez Calso, Frida Vallejo Somohano, Carmen Cauqui Díaz, Gloria Viñas Fernández, Jesús Molina, Marina González Godoy, Gonzalo Lumbreras García, Javier Rosado Martín, Aida Rodríguez Hernández, Sara López Antúñez, Gabriel Vázquez Perfecto, María Concepción Marcello Andrés, Nieves Marina Puente García, Carmen Gil, Ana Martinez, Begoña Soler-López
Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial. Journal of clinical medicine 12 (1) (2022)
Juan A Méndez-Líter, Ana Pozo-Rodríguez, Enrique Madruga, María Rubert, Andrés G Santana, Laura I de Eugenio, Cristina Sánchez, Ana Martinez, Alicia Prieto, Maria Jesus Martinez
Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae : Potential Antiproliferative and Neuroprotective Effect of These Molecules. Antioxidants (Basel, Switzerland) 11 (7) (2022)
Olmo Martín-Cámara, Marina Arribas, Geoffrey Wells, Marcos Morales-Tenorio, Ángeles Martín-Requero, Gracia Porras, Ana Martinez, Giorgio Giorgi, Pilar López-Alvarado, Isabel Lastres-Becker, José Carlos Menéndez
Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. Journal of medicinal chemistry 65 (3) (2022)
Vanesa Nozal, Alfonso García-Rubia, Eva P Cuevas, Concepción Pérez, Carlota Tosat-Bitrián, Fernando Bartolomé, Eva Carro, David Ramírez, Valle Palomo, Ana Martinez
From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis. Angewandte Chemie (International ed. in English) 60 (35) (2021)
Carmen Gil, Ana Martinez
Is drug repurposing really the future of drug discovery or is new innovation truly the way forward? Expert opinion on drug discovery 16 (8) (2021)
Isabel Lastres-Becker, Gracia Porras, Marina Arribas-Blázquez, Inés Maestro, Daniel Borrego-Hernández, Patricia Boya, Sebastián Cerdán, Alberto Garcia Redondo, Ana Martinez, Ángeles Martín-Requero
Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy. International journal of molecular sciences 22 (6) (2021)
Muhammed Kocak, Saba Ezazi Erdi, Guillem Jorba, Ines Maestro, Judith Farrés, Vladimir Kirkin, Ana Martinez, Ole Pless
Targeting autophagy in disease: established and new strategies. Autophagy (2021)
Tiziana Ginex, Urtzi Garaigorta, David Ramírez, Victoria Castro, Vanesa Nozal, Ines Maestro, Javier Garcia-Carceles, Nuria E Campillo, Ana Martinez, Pablo Gastaminza, Carmen Gil
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Javier García-Cárceles, Elena Caballero, Carmen Gil, Ana Martinez
Kinase Inhibitors as Underexplored Antiviral Agents. Journal of medicinal chemistry (2021)
Inés Maestro, Laura R de la Ballina, Anne Simonsen, Patricia Boya, Ana Martinez
Phenotypic Assay Leads to Discovery of Mitophagy Inducers with Therapeutic Potential for Parkinson's Disease. ACS chemical neuroscience (2021)
Rocío Benítez-Fernández, Carolina Melero-Jerez, Carmen Gil, Enrique J de la Rosa, Ana Martinez, Fernando de Castro
Dynamics of Central Remyelination and Treatment Evolution in a Model of Multiple Sclerosis with Optic Coherence Tomography. International journal of molecular sciences 22 (5) (2021)
Enrique Madruga, Ines Maestro, Ana Martinez
Mitophagy Modulation, a New Player in the Race against ALS. International journal of molecular sciences 22 (2) (2021)
Loreto Martínez-González, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Gracia Porras, Eva de Lago, Ángeles Martín-Requero, Ana Martinez
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis. International journal of molecular sciences 22 (16) (2021)
Javier Giglio, Soledad Fernandez, Ana Martinez, Maia Zeni, Laura Reyes, Ana María Rey, Hugo E Cerecetto
Glycogen Synthase Kinase-3 Maleimide Inhibitors As Potential PET-Tracers for Imaging Alzheimer's Disease: 11C-Synthesis and In Vivo Proof of Concept. Journal of medicinal chemistry (2021)
Matthew P Davies, Rocio Benitez, Concepción Perez, Sven Jakupovic, Philip Welsby, Klaudia Rzepecka, Jane Alder, Colin Davidson, Ana Martinez, Joseph M Hayes
Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β. Journal of medicinal chemistry 64 (3) (2021)
Elisa Rojas-Prats, Carlota Tosat-Bitrián, Loreto Martínez-González, Vanesa Nozal, Daniel I Pérez, Ana Martinez
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles. Pharmaceutics 13 (2) (2021)
Eduardo Berenguer, Elena Carneros, Yolanda Pérez-Pérez, Carmen Gil, Ana Martinez, Pilar S Testillano
Small molecule inhibitors of mammalian GSK-3β promote in vitro plant cell reprogramming and somatic embryogenesis in crop and forest species. Journal of experimental botany 72 (22) (2021)
Vanesa Nozal, Elisa Rojas-Prats, Inés Maestro, Carmen Gil, Daniel I Perez, Ana Martinez
Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles. International journal of molecular sciences 22 (6) (2021)
Anabel Rico, Garazi Guembelzu, Valle Palomo, Ana Martinez, Ana Aiastui, Leire Casas-Fraile, Andrea Valls, Adolfo Lopez de Munain, Amets Sáenz
Allosteric Modulation of GSK-3β as a New Therapeutic Approach in Limb Girdle Muscular Dystrophy R1 Calpain 3-Related. International journal of molecular sciences 22 (14) (2021)
Gabriela Vaca, Loreto Martinez-Gonzalez, Ana Fernandez, Elisa Rojas-Prats, Gracia Porras, Eva P Cuevas, Carmen Gil, Ana Martinez, Ángeles Martín-Requero
Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Journal of neurochemistry 156 (3) (2020)
Víctor Sebastián-Pérez, Alfonso García-Rubia, Sayed H Seif El-Din, Abdel-Nasser A Sabra, Naglaa M El-Lakkany, Samia William, Tom L Blundell, Louis Maes, Ana Martinez, Nuria Eugenia Campillo, Sanaa S Botros, Carmen Gil
Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2020)
Valle Palomo, Vanesa Nozal, Elisa Rojas-Prats, Carmen Gil, Ana Martinez
Protein kinase inhibitors for amyotrophic lateral sclerosis therapy. British journal of pharmacology 178 (6) (2020)
Loreto Martínez-González, Carmen Rodríguez-Cueto, Diego Cabezudo, Fernando Bartolomé, Pol Andrés-Benito, Isidro Ferrer, Carmen Gil, Ángeles Martín-Requero, Javier Fernández-Ruiz, Ana Martinez, Eva de Lago
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment. Scientific reports 10 (1) (2020)
Carmen Gil, Tiziana Ginex, Ines Maestro, Vanesa Nozal, Lucía Barrado-Gil, Miguel Ángel Cuesta-Geijo, Jesús Urquiza, David Ramírez, Covadonga Alonso, Nuria Eugenia Campillo, Ana Martinez
COVID-19: Drug Targets and Potential Treatments. Journal of medicinal chemistry 63 (21) (2020)
Rita Maria Concetta Di Martino, Letizia Pruccoli, Alessandra Bisi, Silvia Gobbi, Angela Rampa, Ana Martinez, Concepción Pérez, Loreto Martinez-Gonzalez, Maria Paglione, Elia Di Schiavi, Francesca Seghetti, Andrea Tarozzi, Federica Belluti
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease. ACS chemical neuroscience 11 (17) (2020)
Paula Martínez de Iturrate, Víctor Sebastián-Pérez, Montserrat Nácher-Vázquez, Catherine S Tremper, Despina Smirlis, Julio Martín, Ana Martinez, Nuria Eugenia Campillo, Luis Rivas, Carmen Gil
Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2020)
Inés Maestro, Patricia Boya, Ana Martinez
Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseases. Expert opinion on therapeutic targets 24 (3) (2020)
Valle Palomo, Carlota Tosat-Bitrian, Vanesa Nozal, Siranjeevi Nagaraj, Angeles Martin-Requero, Ana Martinez
TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis. ACS chemical neuroscience 10 (3) (2019)
Víctor Sebastián-Pérez, María Jimena Martínez, Carmen Gil, Nuria Eugenia Campillo, Ana Martinez, Ignacio Ponzoni
QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson's Disease. Journal of integrative bioinformatics 16 (1) (2019)
Josefa Zaldivar-Diez, Lingling Li, Ana M Garcia, Wen-Ning Zhao, Cristina Medina-Menendez, Stephen J Haggarty, Carmen Gil, Aixa V Morales, Ana Martinez
Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate. Journal of medicinal chemistry 63 (5) (2019)
Andrea Canal-Martín, Javier Sastre, María José Sánchez-Barrena, Angeles Canales, Sara Baldominos, Naiara Pascual, Loreto Martínez-González, Dolores Molero, Mª Encarnación Fernández-Valle, Elena Sáez, Patricia Blanco-Gabella, Elena Gómez-Rubio, Sonsoles Martín-Santamaría, Almudena Sáiz, Alicia Mansilla, Francisco Javier Cañada, Jesús Jiménez-Barbero, Ana Martinez, Ruth Pérez-Fernández
Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library. Nature communications 10 (1) (2019)
Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria Eugenia Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez, Maria Laura Bolognesi
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. Journal of medicinal chemistry 61 (17) (2018)
Claudine Kraft, Patricia Boya, Patrice Codogno, Zvulun Elazar, Eeva-Liisa Eskelinen, Judith Farrés, Vladimir Kirkin, Heinz Jungbluth, Ana Martinez, Ole Pless, Charlotte Primard, Tassula Proikas-Cezanne, Anne Simonsen, Fulvio Reggiori
Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy. Autophagy 15 (2) (2018)
Elisa Uliassi, Luis Emiliano Peña-Altamira, Aixa V Morales, Francesca Massenzio, Sabrina Petralla, Michele Rossi, Marinella Roberti, Loreto Martinez Gonzalez, Ana Martinez, Barbara Monti, Maria Laura Bolognesi
A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential. ACS chemical neuroscience 10 (1) (2018)
Carlos Roca, Carlos Requena, Víctor Sebastián-Pérez, Sony Malhotra, Chris Radoux, Concepción Pérez, Ana Martinez, Juan Antonio Páez, Tom L Blundell, Nuria Eugenia Campillo
Identification of new allosteric sites and modulators of AChE through computational and experimental tools. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
M Lourdes Sciú, Víctor Sebastián-Pérez, Loreto Martinez-Gonzalez, Rocio Benitez, Daniel I Perez, Concepción Pérez, Nuria Eugenia Campillo, Ana Martinez, E Laura Moyano
Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2018)
Carlos Roca, Loreto Martinez-González, Miguel Daniel-Mozo, Javier Sastre, Lourdes Infantes, Alicia Mansilla, Antonio Chaves-Sanjuan, Juana María González-Rubio, Carmen Gil, F Javier Cañada, Ana Martinez, María José Sanchez-Barrena, Nuria Eugenia Campillo
Deciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function Regulators. Journal of medicinal chemistry 61 (14) (2018)
Ondrej Benek, Lukas Hroch, Laura Aitken, Frank Gunn-Moore, Lucie Vinklarova, Teodorico C Ramalho, Daniel I Perez, Concepción Pérez, Ana Martinez, Zdenek Fisar, Kamil Musilek
1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Víctor Sebastián-Pérez, Carlos Roca, Mahendra Awale, Jean-Louis Reymond, Ana Martinez, Carmen Gil, Nuria Eugenia Campillo
Medicinal and Biological Chemistry (MBC) Library: An Efficient Source of New Hits. Journal of chemical information and modeling 57 (9) (2017)
Valle Palomo, Daniel I Perez, Carlos Roca, Cara Anderson, Natalia Rodríguez-Muela, Concepción Perez, Jose A Morales-Garcia, Julio A Reyes, Nuria E Campillo, Ana M Perez-Castillo, Lee L Rubin, Lubov Timchenko, Carmen Gil, Ana Martinez
Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases. Journal of medicinal chemistry 60 (12) (2017)

Ana Martinez.css-eqlu8i{font-size:small;padding-left:4px;} (Ana Martínez)

Publication Activity (10 Years)

Top Topics

Top Venues

Ana Martinez (Ana Martínez)